Part D Sponsors Contract Year 2018 Monitoring of Marketed Comprehensive Formularies
Guidance for the dissemination of Part D information are found at 42 C.F.R. §423.128 and Section 100.4 of the Medicare Marketing Guidelines (MMG). Part D sponsors must include on their website their current drug list or formulary, including tier level and any applicable quantity limit restrictions, prior authorization, and step therapy requirements.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: October 24, 2017
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.